Results 111 to 120 of about 12,502 (214)

Amastigotes forms of Trypanosoma cruzi detected in a renal allograft

Revista do Instituto de Medicina Tropical de São Paulo, 1997
Trypanosoma cruzi, the causative agent of Chagas?disease assumes two distinct forms in vertebrate hosts: circulating trypomastigote and tissular amastigote.
CARVALHO Maria Fernanda C., FRANCO Marcello F. de, SOARES Vitor Augusto   +2 more
doaj  

Effect of ureastibamine on Leishmania donovani amastigote.

The Indian journal of medical research, 1990
Ureastibamine, a pentavalent antimonial, reduced the parasitic load in the 60-day model of infection of L. donovani in hamsters. It also inhibited the in vivo multiplication of I donovani amastigotes in hamster peritoneal macrophages. No inhibition in either promastigote multiplication or amastigotes transformation was noted with filtrate obtained ...
A K, Ghosh, K, Mukerji, D K, Ghosh
openaire   +1 more source

NN-assisted image analysis for quantifying intracellular <i>Trypanosoma cruzi</i> infection. [PDF]

Front Cell Infect Microbiol
Iolster J, Vilchez Larrea SC, Alonso GD.
europepmc   +1 more source

Five-layer systems analysis of <i>Leishmania</i> stage differentiation reveals an essential role for protein degradation in parasite development. [PDF]

Elife
Pescher P, Douché T, Giai Gianetto Q, Druart K, Kovářová J, Li B, Cokelaer T, Rajan KS, Piel L, Besse C, Boland A, Deleuze JF, Matondo M, Barrett MP, Michaeli S, Späth GF.   +15 more
europepmc   +1 more source

Natural product-based therapeutic strategies against <i>Leishmania</i>: mechanistic insights and emerging host-directed approaches. [PDF]

Front Microbiol
Verma P, Chaudhary S, Monu M, Aggarwal T, Singh M, Singh A, Kumar V.   +6 more
europepmc   +1 more source

The atypical dual-specificity protein phosphatase (DUSP)/kinatase of Leishmania infantum modulates infectivity, oxidative stress response and antimonial resistance. [PDF]

PLoS Negl Trop Dis
Ribeiro JM, Fonseca GFD, Anbo MAK, Costa KF, Oliveira ACS, Lopes KF, Cruz MGFML, Costa-Silva HM, Santi AMM, Murta SMF.   +9 more
europepmc   +1 more source

A Dual-Reporter Fluorescence-Luminescence Assay for Drug Screening in Promastigote and Intracellular Amastigote Stages of <i>Leishmania</i>. [PDF]

Molecules
D'Alessandro S, Parapini S, Calvo-Alvarez E, Perego F, Mazza G, Murugan A, Basilico N.   +6 more
europepmc   +1 more source

Targeting <i>Leishmania</i> Fe-SOD and Glucose Metabolism with Tripodal and Pyridinacyclophane Polyamines as a Chemotherapeutic Strategy. [PDF]

Metabolites
Martín-Montes Á, Delgado-Pinar E, Bonastre I, Clares MP, Verdejo B, Martínez-Camarena Á, Ballesteros-Garrido R, Martín-Escolano R, Rosales-Lombardo MJ, García-España E, Marín C.   +10 more
europepmc   +1 more source

Design, Synthesis, and Antileishmanial Activity of Novel C6-Substituted Eugenol Derivatives with a Triazole Linker. [PDF]

ACS Omega
Orenha HP, Moncorvo FMSU, Dos Santos T, da Silva GES, Fernandes VHC, Torres-Santos EC, Clososki GC.   +6 more
europepmc   +1 more source

In vitro profiling of Trypanosoma cruzi inhibitors identified from High throughput Screening and application to parasite painting. [PDF]

Int J Parasitol Drugs Drug Resist
Baek KH, Lee H, Byun S, Genilloud O, Ioset JR, Shum D, No JH.   +6 more
europepmc   +1 more source